Anantharaman, K. “Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes”. Kerala Medical Journal, Vol. 1, no. 1, Sept. 2008, pp. 33-34, doi:10.52314/kmj.2008.v1i1.98.